Stem cell shield: could infusions keep COVID-19 at bay?
NCT ID NCT04348435
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether five infusions of stem cells from donated fat tissue could help prevent COVID-19 symptoms and hospital stays in people at high risk of exposure, like healthcare workers and first responders. The trial enrolled 53 participants who had no signs of COVID-19 at the start. Researchers tracked who later developed symptoms or needed hospital care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?